Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Duanduan Cong"'
Autor:
Maurice Canham, Chara Charsou, June Stewart, Sharon Moncur, Laura Hoodless, Ramya Bhatia, Duanduan Cong, Heather Cubie, Camille Busby-Earle, Alistair Williams, Victoria McLoughlin, John D M Campbell, Kate Cuschieri, Sarah Howie
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115379 (2014)
High risk (oncogenic) human papillomavirus (HPV) infection causes cervical cancer. Infections are common but most clear naturally. Persistent infection can progress to cancer. Pre-neoplastic disease (cervical intraepithelial neoplasia/CIN) is classif
Externí odkaz:
https://doaj.org/article/4361bc1b682d471a8bfb55a3cd21615a
Autor:
Duanduan Cong, Jie Song, Yue Liu, Yan Tan, Wei Xue, Xiaohui Liu, Wenyuan Qi, Jun Lu, Xiaojuan Yuan, Yongchun Zhou, Ai-Min Hui, Kexin Li
Publikováno v:
Neurology and Therapy
Introduction This study evaluated the pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple doses of opicapone (OPC) in healthy Chinese and Caucasian subjects. Methods In this open-label, single-center, phase 1 study, eligible Chines
Autor:
Yue Liu, Jie Song, Duanduan Cong, Juan Wang, Liping Zhong, Xiaohui Liu, Ke-Xin Li, Aimin Hui, Changjiang Xu, Wei Xue, Wenyuan Qi, Yan Tan
Publikováno v:
Clinical Pharmacology in Drug Development. 10:1316-1324
Opicapone (OPC) is a third-generation catechol-O-methyltransferase inhibitor developed to treat Parkinson disease and motor fluctuations. This open-label, single-center, phase 1 study aimed to evaluate the pharmacokinetics (PK) of OPC and its metabol
Autor:
Yue Liu, Huolan Zhu, Zuowei Pei, Duanduan Cong, Fang Wang, Chenguang Yang, Ying Guo, Wei Xue, Wenyuan Qi, Min Dong
Publikováno v:
Pharmacogenomics and Personalized Medicine
Yue Liu,1,* Chenguang Yang,2,* Wenyuan Qi,1 Zuowei Pei,2 Wei Xue,1 Huolan Zhu,2 Min Dong,2 Ying Guo,2 Duanduan Cong,1 Fang Wang2 1Clinical Trial Center, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Scien
Autor:
Fei Zhao, Wei Xue, Wenyuan Qi, Duanduan Cong, Huiqing Yao, Yue Liu, Juan Wang, Xiaohui Liu, Hongyan Li, Zhihe Liu, Qingqing Wang, Chunyi Fu, Xin Hu, Kexin Li
BACKGROUND Background: World health organization and the international committee of medical journal editors call for clinical trial registration before the start of the recruitment of participants. The registration promotes transparency and accessibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d09447f41ebc56e240a57472810f5fed
https://doi.org/10.2196/preprints.26258
https://doi.org/10.2196/preprints.26258
Autor:
Kate Cuschieri, June Stewart, Sharon Moncur, Alistair R.W. Williams, John D.M. Campbell, Sarah E. M. Howie, Duanduan Cong, Camille Busby-Earle, Heather Cubie, Victoria McLoughlin, Laura J. Hoodless, Maurice A. Canham, Ramya Bhatia, Chara Charsou
Publikováno v:
Canham, M, Charsou, C, Stewart, J, Moncur, S, Hoodless, L, Bhatia, R, Cong, D, Cubie, H, Busby-Earle, C, Williams, A, McLoughlin, V, Campbell, J D M, Cuschieri, K & Howie, S 2014, ' Increased Cycling Cell Numbers and Stem Cell Associated Proteins as Potential Biomarkers for High Grade Human Papillomavirus+ve Pre-Neoplastic Cervical Disease ', PLoS ONE, vol. 9, no. 12, e115379 . https://doi.org/10.1371/journal.pone.0115379
PLoS ONE
PLoS ONE, Vol 9, Iss 12, p e115379 (2014)
PLoS ONE
PLoS ONE, Vol 9, Iss 12, p e115379 (2014)
High risk (oncogenic) human papillomavirus (HPV) infection causes cervical cancer. Infections are common but most clear naturally. Persistent infection can progress to cancer. Pre-neoplastic disease (cervical intraepithelial neoplasia/CIN) is classif